DR LALCHANDANI LABS LIMITED

About

Dr Lalchandani Labs Limited provides diagnostic and related healthcare tests and services in India. The company offers doctor consultation, pathology, radiology, hospital lab management, corporate health checkup, and blood bank services, as well as X-ray, TMT, ultrasound, 2D-echo, and medical fitness examinations. It also offers its products online. The company serves individual patients, hospitals and other healthcare providers, and corporate customers. Dr Lalchandani Labs Limited was founded in 1986 and is based in New Delhi, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Sales	4.19	4.45	4.81	5.04	11.28	9.78	6.10	5.26	2.79
Expenses	3.50	3.52	4.59	4.95	8.81	7.54	4.84	4.06	2.17
Operating Profit	0.69	0.93	0.22	0.09	2.47	2.24	1.26	1.20	0.62
OPM %	16.47	20.90	4.57	1.79	21.90	22.90	20.66	22.81	22.22
Other Income	0.00	0.13	1.40	0.00	0.00	0.00	0.00	0.01	0.03
Interest	0.02	0.09	0.38	0.99	0.60	0.35	0.18	0.14	0.16
Depreciation	0.57	0.56	0.62	0.66	0.59	0.52	0.42	0.35	0.13
Profit before tax	0.10	0.41	0.62	-1.56	1.28	1.37	0.66	0.72	0.36
Tax %	30.00	-2.44	0.00	0.00	28.12	26.28	28.79	26.39	25.00
Net Profit	0.06	0.42	0.62	-1.56	0.93	1.01	0.47	0.53	0.26
EPS in Rs	0.07	0.48	0.71	-1.79	1.07	1.16	0.54	0.61	0.44
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Equity Capital	8.64	4.33	4.33	4.33	4.33	4.33	4.33	4.33	2.93
Reserves	5.50	5.62	5.21	4.59	6.15	5.22	4.21	3.73	0.40
Borrowings	2.06	4.07	3.48	6.40	5.15	4.04	1.76	0.90	1.88
Other Liabilities	1.40	1.72	1.97	2.40	2.49	1.61	1.63	1.18	1.00
Total Liabilities	17.60	15.74	14.99	17.72	18.12	15.20	11.93	10.14	6.21
Fixed Assets	3.27	3.51	3.99	5.39	5.75	5.24	3.47	3.28	2.06
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.27	0.27	0.41	0.24	0.24	0.24	0.24	0.24	0.24
Other Assets	14.06	11.96	10.59	12.09	12.13	9.72	8.22	6.62	3.91
Total Assets	17.60	15.74	14.99	17.72	18.12	15.20	11.93	10.14	6.21

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Cash from Operating Activity	-0.76	0.37	-0.22	0.00	2.01	1.19	-0.10	-0.45	0.58
Cash from Investing Activity	-0.51	0.06	1.00	-0.20	-1.53	-2.26	-0.53	-1.95	-1.29
Cash from Financing Activity	2.12	0.58	-1.59	-0.23	0.16	1.71	0.85	3.51	1.57
Net Cash Flow	0.84	1.01	-0.81	-0.43	0.64	0.64	0.23	1.12	0.85
Free Cash Flow	-1.09	0.30	0.74	-0.30	0.91	-1.10	-0.71	-2.39	-0.73
CFO/OP %	-110.00	40.00	-100.00	0.00	95.00	67.00	5.00	-32.00	94.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Debtor Days	532.26	431.44	356.65	359.93	136.55	148.54	199.25	126.99	149.14
Inventory Days	306.69	490.47	255.15	458.51	191.07	68.75	158.70	233.36	167.03
Days Payable	110.15	365.00	217.94	404.21	175.15	97.06	355.48	406.89	426.86
Cash Conversion Cycle	728.79	556.91	393.86	414.23	152.47	120.23	2.47	-46.54	-110.69
Working Capital Days	460.82	156.66	163.91	188.29	77.98	104.50	206.43	167.23	162.22
ROCE %	0.79	2.81	-2.68	-3.68	12.87	14.40	8.72	12.14	—

Shareholding Pattern

% holding — latest first

Holder	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Sep 2023	Mar 2023	Sep 2022	Mar 2022	Sep 2021	Mar 2021	Sep 2020
Promoters	32.90	31.15	48.32	57.18	60.78	60.78	60.78	60.78	60.78	60.78	60.78	60.78
Public	67.10	68.84	51.68	42.82	39.22	39.21	39.22	39.23	39.22	39.22	39.22	39.22
No. of Shareholders	233	206	246	181	165	159	164	162	157	151	143	143